Navigation Links
OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
Date:12/10/2007

ATLANTA An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer.

Researchers working with the cancer mutation in the JAK2 enzyme have found that the enzyme is dependent on the hormone TNF-alpha to grow and cause a red blood cell cancer called polycythemia vera, said principal investigator Thomas Bumm, M.D., Ph.D., OHSU Cancer Institute member.

This research will be presented at the American Society of Hematology annual meeting in Atlanta on Monday, Dec. 10, at 3:30 p.m.

Polycythemia vera is a disease in which there are too many red blood cells in the bone marrow and blood, causing the blood to thicken. There is no cure.

Mice with normal TNF-alpha production and the JAK2 mutation developed the red blood cell disease very quickly within two to three weeks. The blood became very thick, and they developed severe bone marrow fibrosis, excessive fibers in the bone marrow with a decrease in healthy cells. In contrast, mice without the hormone but carrying the JAK2 mutation had normal red blood cell levels and normal bone marrow.

The hormone, TNF-alpha is known as a highly potent hormone, but until now its role in cancer has not been well understood.

If these specific hormones are understood, then there is hope to find a new way to fight these cancer cells by attacking the specific hormones triggering the cancer cells, said Bumm, a fellow in hematology/ medical oncology, OHSU School of Medicine.

There are already drugs developed that target TNF-alpha used for patients with auto immune and inflammatory diseases such as rheumatoid arthritis. But the drugs have not been used for cancer patients. Bumm said one of the next steps will be to conduct studies on a larger mouse study and also testing these different drugs effect on this JAK2-induced cancer.

M
'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 Shabaikai is an ... forests of the Pomo Indians located on the shores ... the river Shabaikai, meaning ‘crooked snake’. Clarkson takes the ... and the violence of prohibition and organized crime, providing ... River. Here, the most powerful men in the world ...
(Date:7/30/2014)... Antonio, TX (PRWEB) July 30, 2014 ... with Christus Spohn Health, recently announced the proposed naming ... TX: the Dr. Hector P. Garcia Family Health Center. ... state-of-the-art primary health care services, including comprehensive chronic disease ... It will also be a pioneering medical home model ...
(Date:7/30/2014)... July 30, 2014 Naomi Fried, ... the Board of Directors of the American Telemedicine ... the Association, which has a mission to promote ... through telecommunications and information technology. , “Both Naomi ... Association, possess extraordinary expertise and are well known ...
(Date:7/30/2014)... have identified a protein that could help doctors decide ... that makes radiotherapy more effective, according to a study* ... (BJC). , The team from The University of Manchester, ... whose bladder tumour had high levels of a protein, ... carbogen oxygen mixed with carbon dioxide gas ...
(Date:7/30/2014)... Rhode Island Hospital researchers have found that a ... reduce depression and other symptoms in informal caregivers, ... dementia. The study is published online in advance ... Dementia . , "Those caring for people with ... often under a great deal of pressure," said ...
Breaking Medicine News(10 mins):Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Scientists pinpoint bladder cancer patients who could benefit from 'tumor-softening' treatment 2Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... "fused" with a groupa bond even stronger than group identificationwill ... outsiders, conclude researchers in a new study published in ... Science. This intense bond to a group may help explain ... B. Swann, Jr., of the University of Texas, came up ...
... and adolescents have become fatter over the last ... Bloomberg School of Public Health and National Institute ... across socio-demographic groups over time and found U.S. ... such as body mass index (BMI), waist circumference ...
... and women in the Troms Study in northern Norway has reported ... cognitive tests. The subjects (average age 58 and free of ... with a range of cognitive function tests. Among women, there was ... consumed wine at least 4 or more times over two ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Aug. ... of imaging to guide the needle now make up the majority ... the use of these minimally invasive biopsies increased from 59 percent ... trend which is likely to continue, one expert noted. A biopsy ...
... (CLASS) Act a largely overlooked component of the 2010 ... to transform long-term care financing in the United States from ... issue of Public Policy & Aging Report ... SCAN Foundation , this installment of PPAR features ...
Cached Medicine News:Health News:People with 'fused' identities are willing to die for their social group 2Health News:Overweight American children and adolescents becoming fatter 2Health News:Moderate drinking, especially wine, associated with better cognitive function 2Health News:Less Invasive Biopsies Gain Favor 2Health News:CLASS Act analysis reveals America's long-term care future 2
(Date:7/30/2014)... , July 30, 2014   Unique Pizza ... Inc.: OTC Pink: UPZS), a Delaware Corporation, is ... agreement with Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical ... to the agreement, US-based Larasan will work with ... frozen pizza through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: